Антигенный дрейф коклюшного микроба

12.01.2008

Литература

  1. Бабаченко И.В., Курова Н.Н., Ценева Г.Я. Молекулярно-генетические и клинические особенности коклюшной и паракоклюшной инфекций в Санкт-Петербурге // Эпидемиология и инфекционные болезни. 2005. № 6. С. 41-45.
  2. Бабаченко И.В., Мартыкин А.С., Кузьмин А.И. и др. Современные аспекты коклюша у детей // Педиатрия. 1994. № 3. С. 66-70.
  3. Бабаченко И.В., Курова Н.Н., Ценева Г.Я. Коклюшная инфекция в условиях антигенного дрейфа Bordetella pertussis // Вопросы современной педиатрии. 2006. Т. 5. С. 24-27.
  4. Попова О.П., Петрова М.С., Чистякова Г.Г. и др. Клиника коклюша и серологические варианты коклюшного микроба в современных условиях // Эпидемиология и инфекционные болезни. 2005. № 1. С. 44-46.
  5. Попова О.П., Селезнева Т.С., Милюкова В.И. Клинико-эпидемиоло-гические аспекты коклюшной инфекции в современных условиях // Эпидемиология инфекционные болезни. 1999. № 3. С. 24-26.
  6. Семенов Б.Ф., Захарова Н.С., Мазурова И.К. Подъем заболеваемости коклюшем на фоне массовой вакцинации. Гипотезы, объясняющие этот феномен // Микробиология. 2003. № 6. С. 70-73.
  7. Andrew R., Herceq A., Roberts С. Pertussis notifications in Australia // Commun. Dis. Intell., 1997. V. 21. P 145-148.
  8. Arico B., Gross R., Smida J. et al. Evolutionary relationships in the genus Bordetella // Mol. Microbiol., 1987. V. l. P 301-308.
  9. Bass J.W., Stephensen S.R. The return of pertussis // Pediatr. Infect. Dis. J., 1987. V. 6. P. 141-144.
  10. Bass J.W., Wittler R.R. Return of epidemic pertussis in the United States // Pediatr. Infect. Dis. J., 1994. V. 13. P 343-345.
  11. Caro V., Njamkepo E., Van Amersfoorth S.C. et al. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies // Microbes Infect., 2005. V. 7. P. 976-982.
  12. Cassiday P, Sanden G., Heuvelman K. et al. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935 - 1999 // J. Infect. Dis., 2000. V. 182. P. 1402-1408.
  13. Charles I.G., Dougan G., Pickard D. et al. Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis // PNAS, 1989. V. 86. P 3554-3558.
  14. Charles I.G., Li J.L., Roberts M. et al. Identification and characterization of a protective immunominant B cell epitope of pertactin (P.69) from Bordetella pertussis// Eur. J. Immunol., 1991. V. 21. P. 1147-1153.
  15. Charles I.G., Fairweather N., Pickard D. et al. Expression of the Bordetella pertussis P69 pertactin adhesion in Escherichia coli: fate of the carboxy-terminal domain // Microbiology, 1994. V. 140. P 3301-3308.
  16. De Melker H.E., Conyn-van Spaendock M.A.E., Rumke H.C. et al. Pertussis in the Netherlands: an outbreak despite high level of immunization with whole cell vaccine // Emerg. Infect. Dis., 1997. V. 3. P 175-178.
  17. Fry N.K., Neal S., Harrison T.G. et al. Genotypic variation the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom // Infect. Immun., 2001. V. 69. P. 5520-5528.
  18. Hallander H.O., Advani A., Donnely D. et al. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs // J. Clin. Microbiology, 2005. V. 43. P. 2856-2865.
  19. Hardwick T.H., Cassiday P., Weyant R.C. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999 // Emerg. Infect. Dis., 2002. V. 8. № 1. P. 44-49.
  20. Khelef N., Danve B., Quentin-Millet M.J. et al. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species // Infect. Immun., 1993. V. 61. P. 486-490.
  21. Kobish M., Novotny P. Identification of a 68-kilodalton outer membrane protein as the major protective antigen of Bordetella bronchiseptica by using specific-pathogen-free piglets // Infect. Immun., 1990. V. 58. P. 352-357.
  22. Kourova N., Caro V., Weber С. et al. Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains // J. Clin. Microb., 2003. V. 41. P. 3707-3711.
  23. Leininger E., Ewanowich C.A., Bhargava A. et al. Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglulutinin // Infect. Immun., 1992. V. 60. P. 2380-2385.
  24. Li L.J., Fairweather N.F., Novotny P et al. Cloning, nucleotide sequence and heterologous expression of the protective outer membrane P.68 pertactin from Bordetella bronchiseptica // J. Gen. Microbiology, 1992. V. 138. P. 1697-1705.
  25. Locht C., Keith J.M. Pertussis toxin gene: nucleotide sequence and genetic organization // Science, 1986. V. 232. P 1258-1264.
  26. Loosmore C., Cunningham J., Bradley et al. A unique sequence of the Bordetella pertussis toxin operon // Nucleic Acids Res., 1989. V. 17. P. 8365.
  27. Mooi F.R., van Oirschot H., Heuvelman K., van der Heide H.G.J., Gaastra W., Willems J.L. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine-driven evolution // Infect. Immun., 1998. № 66. P. 670-675.
  28. Mooi F.R., Qiushui H., van Oirschot H., Mertsola J. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland // Infect. Immun., 1999. № 67. P. 3133, 3134.
  29. Nicosia A., Peragini M., Frangini M., Frangini C. et al. Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplination // PNAS, 1986. V. 83. P. 4631-4635.
  30. Ochman H., Wilson A.C. Evаluation in bacteria: evidence for a universal substitution rate in cellular genomes // J. Mol. Evol., 1987. V. 26. P. 74-86.
  31. Van der Zee A., Vernooij S., Peeters M. et al. Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and postvaccination strains and global distribution // Microbiology, 1996. V. 42. P. 3479-3485.
  32. Van Loo J.H.M., van der Heide G.J., Nagelkerke N.J.D. et al. Temporal trends in the population structure of Bordetella pertussis during 1949 - 1996 in highly vaccinated population // J. Infect. Dis., 1999. V. 179. P. 915-923.
  33. Weber C., Boursaux-Eude C., Coralie G. et al. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years // J. Clin. Microbiol., 2001. V. 39. P. 4396-4403.
  34. Willems R.J.L., Mooi F.R. From whole cell to acellular vaccines // Rev. Med. Microbiol., 1996. V. 7. P 13-21.

И.Э. Борисова, Т.С. Селезнева Антигенный дрейф коклюшного микроба // Эпидемиология и вакцинопрофилактика 2008, №38, стр. 39-43